BIOLIFE SOLUTIONS INC 8-K

What Happened

• BioLife Solutions, Inc. filed a Form 8-K (Item 5.02) reporting that Karen Foster, the Company’s Chief Quality and Operations Officer, notified the company on January 8, 2026 that she will retire effective March 31, 2026.
• The filing, dated January 9, 2026 and signed by CFO Troy Wichterman, states Ms. Foster’s retirement is not the result of any disagreement with the company’s operations, policies or practices.

Key Details

• Notice date: January 8, 2026.
• Effective retirement date: March 31, 2026.
• Filing: Form 8-K, Item 5.02, filed January 9, 2026 (signed by Troy Wichterman, CFO).
• The company disclosed no disagreement with Ms. Foster and did not identify a successor or any compensatory arrangements in the filing.

Why It Matters

• This is a leadership change in a senior role responsible for quality and operations—areas that can affect manufacturing, product quality, and regulatory compliance.
• The filing contains no indication of operational problems or disputes, but investors should watch for future disclosures about a successor, transition plan, or any related compensation arrangements that could affect operations or costs.